Therefore, FISH continues to be used as a screening method in some instances, for example when testing RET in a sequential algorithm, especially in EGFR-, KRAS-, ALK- and ROS1-negative NSCLC samples and/or when NGS or RT-PCR are not available or technically feasible. This evidence concerns the gene ALK and non-small cell lung carcinoma.